PATIENT FEEDBACK FOR CONTROL OF ULTRASOUND DEEP-BRAIN NEUROMODULATION

• US 20110178442A1
• Filed: 01/15/2011
• Published: 07/21/2011
• Est. Priority Date: 01/18/2010
• Status: Abandoned Application

• Current Assignee: David J. Mishelevich
• Original Assignee: David J. Mishelevich
• Inventors: Mishelevich, David J.
• Application Number:
  US13/007,626
• Publication Number:
  US 20110178442A1
• Time in Patent Office: Days
• US Class Current: 601/2
• CPC Class Codes: A61B 2018/00642 with feedback, i.e. closed loop control
• CPC Class Codes: A61N 2007/0026 Stimulation of nerve tissue
• CPC Class Codes: A61N 2007/0078 with multiple treatment transducers
• CPC Class Codes: A61N 2007/0095 by modifying an excitation signal
• CPC Class Codes: A61N 2007/027 with multiple foci created simultaneously
• CPC Class Codes: A61N 7/00 Ultrasound therapy lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 ; using ultrasound for introducing media into the body A61M37/0092

Abstract

Disclosed are methods and systems and methods for patient-feedback control of non-invasive deep brain or superficial neuromodulation using sound impacting one or multiple points in a neural circuit to produce acute effects and, with application in multiple sessions, Long-Term Potentiation (LTP) or Long-Term Depression (LTD) to treat indications such as neurologic and psychiatric conditions. One or more of sonic transducer positioning, intensity, frequency, dynamic sweeps, phase/intensity relationships, and firing patterns are changed through feedback from the patient to optimize patient experience through up-regulation or down regulation. Examples are decreases in acute pain or tremor due to more effective impact on the neural targets.

Claims

1. A method of modulating a deep-brain targets using ultrasound neuromodulation, the method comprising:

a mechanism for aiming one or a plurality of ultrasound transducers at one or more a deep-brain targets;

applying power to each of the ultrasound transducers via a control circuit thereby modulating the activity of the deep brain target region;

providing a mechanism for feedback from the patient based on the acute sensory or motor conditions of the patient; and

using that feedback to control one or more parameters to maximize the desired effect.

2. The method of claim 1, further comprising neuromodulation in a manner selected from the group of up-regulation, down-regulation.

3. The method of claim 1, wherein the means of control is orienting one or a plurality of ultrasound transducers.

4. The method of claim 1, wherein the means of control is adjusting the pulse frequency of one or a plurality of ultrasound transducers.

5. The method of claim 1, wherein the means of control is adjusting the phase/intensity relationships within and among the plurality of ultrasound transducers.

6. The method of claim 1, wherein the means of control is adjusting the intensity relationships within an ultrasound transducer or among a plurality of ultrasound transducers.

7. The method of claim 1, wherein the means of control is adjusting the fire patterns within an ultrasound transducer or among a plurality of ultrasound transducers.

8. The method of claim 1, wherein the means of control is adjusting the dynamic sweeps of a dynamic ultrasound transducer or a plurality of dynamic ultrasound transducers.

9. The method of claim 1, wherein the acoustic ultrasound frequency is in the range of 0.3 MHz to 0.8 MHz.

10. The method of claim 1, where in the power applied is less than 180 mW/cm².

11. The method of claim 1, wherein the power applied is greater than 180 mW/cm² but less than that causing tissue damage.

12. The method of claim 1, wherein a stimulation frequency for of 300 Hz or lower is applied for inhibition of neural activity.

13. The method of claim 1, wherein the stimulation frequency for excitation is in the range of 500 Hz to 5 MHz.

14. The method of claim 1, wherein the focus area of the pulsed ultrasound is 0.5 to 1500 mm in diameter.

15. The method of claim 1 where one effect is used as a surrogate for another effect.

16. The method of claim 15 where the first effect is acute pain and the second effect is chronic pain.

17. The method of claim 1, wherein a disorder is treated by neural neuromodulation, the method comprising modulating the activity of one target brain region or simultaneously modulating the activity of a plurality target brain regions, wherein the target brain regions are selected from the group consisting of NeoCortex, any of the subregions of the Pre-Frontal Cortex, Orbito-Frontal Cortex (OFC), Cingulate Genu, subregions of the Cingulate Gyms, Insula, Amygdala, subregions of the Internal Capsule, Nucleus Accumbens, Hippocampus, Temporal Lobes, Globus Pallidus, subregions of the Thalamus, subregions of the Hypothalamus, Cerebellum, Brainstem, Pons, or any of the tracts between the brain targets.

18. The method of claim 1, wherein the disorder treated is selected from the group consisting of pain, Parkinson'"'"'s Disease, depression, bipolar disorder, tinnitus, addiction, OCD, Tourette'"'"'s Syndrome, ticks, cognitive enhancement, hedonic stimulation, diagnostic applications, and research functions.

19. The method of claim 1, wherein Transcranial Magnetic Stimulation coils are used in place or ultrasound transducers.

20. The method of claim 1 wherein the feedback control of ultrasound transducers is combined with the application, with or without feedback control, of one or more other modalities selected from the group of deep-brain stimulators (DBS) using implanted electrodes, Transcranial Magnetic Stimulation (TMS), transcranial Direct Current Stimulation (tDCS), implanted optical stimulation, stereotactic radiosurgery, Radio-Frequency (RF) stimulation, vagus nerve stimulation, or functional stimulation.